VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X:
”In an insightful recent interview, Carmelo Carlo-Stella (Humanitas University) speaks on the role of TP53 and ctDNA kinetics in patients with relapsed or refractory diffuse large B-cell lymphoma treated with glofitamab monotherapy. Watch here.”
Source: VJHemOnc/X